Phoenix Biotech Acquisition (PBAXU) Stock Price, News & Analysis

Company Overview

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.

Key Stats

• Today's Range: $10.37 to $10.37
• 50-Day Range: $10.37 to $10.37
• 52-Week Range: $9.82 to $11.73
• Volume: 7 shs
• Average Volume: 533 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PBAXU Stock Analysis - Frequently Asked Questions

When did Phoenix Biotech Acquisition IPO?

Phoenix Biotech Acquisition (PBAXU) raised $155 million in an IPO on Wednesday, October 6th 2021. The company issued 15,500,000 shares at $10.00 per share.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:PBAXU
• CIK: 1870404
• Web: www.phoenixbiotechacquisitioncorp.com
• Phone: 215-731-9450
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A